aTyr Pharma ATYR Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | $190K0.0% | $190K— | $0— | $0-100% | ||
| $55.72M-7.5% | $60.22M-2.2% | $61.56M+13.5% | $54.23M+2.7% | $52.82M-2.9% | ||
| $17.76M+0.9% | $17.6M+1.8% | $17.29M+9.3% | $15.82M+11.2% | $14.23M+3.3% | ||
| $73.48M-5.6% | $77.82M-1.3% | $78.84M+12.6% | $70.05M+4.5% | $67.05M-1.6% | ||
| -$73.29M+5.6% | -$77.63M+1.3% | -$78.65M-12.3% | -$70.05M-4.5% | -$67.05M+1.3% | ||
| $3.26M-7.1% | $3.5M-0.6% | $3.52M+3.4% | $3.41M-6.3% | $3.64M-6.6% | ||
| -$70.03M+5.5% | -$74.12M+1.3% | -$75.12M-12.7% | -$66.64M-5.1% | -$63.41M+1.0% | ||
| -$0.73+7.6% | -$0.79+3.7% | -$0.82-3.8% | -$0.79+1.3% | -$0.80+7.0% | ||
| -$72.63M+5.6% | -$76.96M+1.3% | -$77.98M-12.4% | -$69.36M-4.5% | -$66.35M+1.3% | ||
| -$73.29M+5.6% | -$77.63M+1.3% | -$78.65M-12.3% | -$70.05M-4.5% | -$67.05M+1.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is aTyr Pharma's revenue?
- aTyr Pharma (ATYR) generated $190.0K in revenue over the trailing twelve months, down 19.1% year over year.
- Is aTyr Pharma profitable?
- aTyr Pharma is not currently profitable: it reported a net loss of $70.0M over the trailing twelve months, a -39009.5% net margin.
- What is aTyr Pharma's earnings per share?
- aTyr Pharma's diluted EPS over the trailing twelve months is $-0.73.
- Where does aTyr Pharma's income statement data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
